Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 EGP | -1.83% | +8.04% | +30.30% |
Sales 2024 * | 2.92B 62.53M | Sales 2025 * | 3.53B 75.72M | Capitalization | 3.2B 68.68M |
---|---|---|---|---|---|
Net income 2024 * | 388M 8.31M | Net income 2025 * | 534M 11.44M | EV / Sales 2024 * | 1.46 x |
Net Debt 2024 * | 1.07B 22.86M | Net Debt 2025 * | 766M 16.42M | EV / Sales 2025 * | 1.12 x |
P/E ratio 2024 * |
7.24
x | P/E ratio 2025 * |
5.53
x | Employees | - |
Yield 2024 * |
4.93% | Yield 2025 * |
8.19% | Free-Float | 50.28% |
1 day | -1.83% | ||
1 week | +8.04% | ||
Current month | +4.37% | ||
1 month | -13.65% | ||
3 months | -26.87% | ||
6 months | +39.70% | ||
Current year | +30.30% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 2.15 | -1.83% | 7,549,985 |
24-05-19 | 2.19 | +6.83% | 7,924,592 |
24-05-16 | 2.05 | +3.54% | 7,047,411 |
24-05-15 | 1.98 | -0.50% | 3,123,296 |
24-05-14 | 1.99 | 0.00% | 1,961,645 |
End-of-day quote Egyptian Exchange, May 19, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.30% | 68.71M | |
+34.35% | 705B | |
+30.84% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.53% | 238B | |
-3.31% | 210B | |
+10.24% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- RMDA Stock